InsidersTradesSigma
Track the BIO share price and the full insider trade history of the company, a listed equity based in Australia. Shares are listed on the AU market, under the supervision of ASX. Market capitalisation: €61.6m. The latest transaction was filed on 25 June 2026 (Purchase). Among the most active insiders: Blair Vega Norfolk. All data is free.
Analysts rate BIO Strong Buy (bullish), based on 1 analysts. Average price target: A$0.75.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
BIO es una empresa que cotiza en el mercado XASX, especializada en el sector de la biotecnología. Se centra en el desarrollo de soluciones innovadoras para la salud.